The Drug Security Forum
will be held on the opening day of the St. Petersburg International Economic
Forum. Its business programme will include expert discussions on the Russian
pharmaceutical industry’s growth strategies and the role of those strategies in
ensuring national drug security.
The COVID-19 pandemic
has highlighted the issue of national drug security and has given a new
perspective to the development strategies of the Russian pharmaceutical
industry. Import independence and innovation are key to strengthening Russia’s
pharmaceutical industry. The country must also develop a domestic active
pharmaceutical ingredient (API) manufacturing network and create conditions
that foster innovation in the Russian pharmaceutical industry. Not only will
supporting domestic pharmaceutical lifecycle management and shifting the
regulatory focus from expanding generic product portfolios to launching a
complete range of domestic innovative preparations bolster national drug
security, it will also increase the competitiveness of the Russian
pharmaceutical industry, raising it to the rank of global market leader.
“The pharmaceutical
industry support measures implemented in the Russian Federation over the last
several years have taken operations to the next level. The Russian
pharmaceutical industry has proven that it can operate effectively and without
interruptions, even during a pandemic. The drugs that we are developing and
manufacturing are not only satisfying domestic market demand, they are also
showing promising export potential,” said Aleksander Petrov, Chairman of the
Subcommittee on the Circulation of Medicines and Pharmaceutical and Medical
Industry Development, part of the Committee on Health Protection of the State
Duma of the Russian Federation.
Participants of the
session ‘Growth Strategy of the Russian Pharma Industry as a Basis of National
Drug Security’, will discuss the regulatory solutions and government
incentives Russia needs to create a new, competitive API manufacturing
industry, the government support and regulatory instruments with the potential
to stimulate innovation in the Russian pharmaceutical industry, and other
development measures the national pharmaceutical industry could use to address
expanding access to and the variety of available medicines, drug list planning,
deficit prevention, and other topical issues.
The
Drug Security Forum is organized by the Roscongress Foundation and the Content
Foundation for Expertise and Analysis. The Forum is organized with the support
of the Ministry of Health of the Russian Federation and the Subcommittee on the
Circulation of Medicines and Pharmaceutical and Medical Industry Development,
part of the Committee on Health Protection of the State Duma of the Russian
Federation.
The
session is held with the support of Pharmasyntez Group.
Official Drug Security Forum website: pharmforum.org
